ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
285
|
81K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
285
|
81K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Institutional investment to pursue strategic initiatives
|
|
64palms
|
25 |
5.5K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
25
|
5.5K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Institutional investment to pursue strategic initiatives
|
|
64palms
|
25 |
5.5K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
25
|
5.5K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Institutional investment to pursue strategic initiatives
|
|
64palms
|
25 |
5.5K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
25
|
5.5K
|
2
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
64palms
|
117 |
45K |
3 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
117
|
45K
|
3
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
64palms
|
117 |
45K |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
117
|
45K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
64palms
|
117 |
45K |
2 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
117
|
45K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
285
|
81K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
64palms
|
2.9K |
708K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
2.9K
|
708K
|
4
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
818
|
152K
|
4
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
818
|
152K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
818
|
152K
|
6
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Investor webinar presentation
|
|
64palms
|
32 |
6.6K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
32
|
6.6K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
64palms
|
18 |
3.8K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
3.8K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
64palms
|
18 |
3.8K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
18
|
3.8K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Institutional investment to pursue strategic initiatives
|
|
64palms
|
25 |
5.5K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
25
|
5.5K
|
7
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
14 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
818
|
152K
|
14
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Notification of Expiry of Listed Options
|
|
64palms
|
6 |
1.1K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
6
|
1.1K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
285
|
81K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
285
|
81K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
81K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
3
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
152K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
152K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
20 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
152K
|
20
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
81K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
Ann: Carolina Lithium State Mining Permit
|
|
64palms
|
151 |
53K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
151
|
53K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
152K
|
0
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
152K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
152K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
126
|
26K
|
5
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
126
|
26K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: 3Q FY24 results update
|
|
64palms
|
460 |
83K |
11 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
460
|
83K
|
11
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
152K |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
818
|
152K
|
11
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
81K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
81K
|
3
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
81K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
81K
|
6
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Investor Presentation - Angola Rising
|
|
64palms
|
605 |
133K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
605
|
133K
|
8
|
|